| Breakdown | TTM | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 88.43B | 86.29B | 83.67B | 86.38B | 97.06B | 96.25B |
| Gross Profit | 29.89B | 28.89B | 26.15B | 27.13B | 30.49B | 30.39B |
| EBITDA | 11.50B | 10.69B | 12.59B | 13.57B | 12.69B | 14.47B |
| Net Income | 6.64B | 6.65B | 6.96B | 7.73B | 6.44B | 8.44B |
Balance Sheet | ||||||
| Total Assets | 54.94B | 54.14B | 44.57B | 43.36B | 45.27B | 46.33B |
| Cash, Cash Equivalents and Short-Term Investments | 1.24B | 1.35B | 2.13B | 1.23B | 1.73B | 1.40B |
| Total Debt | 42.54B | 44.68B | 39.68B | 40.15B | 37.99B | 29.38B |
| Total Liabilities | 64.21B | 64.06B | 58.80B | 58.41B | 59.53B | 51.15B |
| Stockholders Equity | -9.27B | -9.92B | -14.23B | -15.05B | -14.25B | -4.82B |
Cash Flow | ||||||
| Free Cash Flow | 7.62B | 7.65B | 7.70B | 6.18B | 6.76B | 8.26B |
| Operating Cash Flow | 9.84B | 9.86B | 9.63B | 8.14B | 8.59B | 10.11B |
| Investing Cash Flow | -12.23B | -12.26B | -1.74B | -1.90B | -1.31B | -1.65B |
| Financing Cash Flow | 129.00M | 1.62B | -7.05B | -6.67B | -7.05B | -12.02B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | $24.00B | 22.52 | 53.29% | 1.37% | 1.30% | 1.14% | |
63 Neutral | $310.62B | 22.20 | 113.30% | 2.67% | 2.23% | -4.48% | |
62 Neutral | $15.74B | 14.18 | 42.57% | 1.80% | 4.64% | 1.15% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | $15.33B | 13.20 | 38.34% | 5.46% | 0.99% | 31.91% | |
56 Neutral | $115.86B | 17.48 | -64.84% | 1.94% | 6.24% | -2.12% | |
53 Neutral | $5.47B | 26.77 | 8.38% | ― | 3.46% | -3.01% |